FIGURE 3.
Results of serum validation for metabolite markers discovered in tissue. (A) Diagram of recruited cohort of healthy donor (HD), TNBC patients, CPSI-MS screening for serum metabolomics, and machine learning process; (B) Venn graphs display the number of metabolites that are finally selected as serum screening markers and used for quantitative estimation; (C) Heatmap visualization indicate the consistent tendencies of these characteristic metabolites in tissue and serum; (D) The quantitative comparison of representative 10 metabolite markers in serum; (E) The scores predicted by Lasso classifier on the 381 TNBC and HD serum samples; (F) Histograms display the distribution of HD and TNBC samples in the training and test sets; (G) ROC curve for assessing the performances of the metabolite markers-based Lasso model for TNBC screening. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.